BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10582488)

  • 1. [Molecular pathology of colorectal cancer].
    Bosman FT; Joris F
    Rev Med Suisse Romande; 1999 Oct; 119(10):775-82. PubMed ID: 10582488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathology of colorectal cancer.
    Bosman FT
    Cytogenet Cell Genet; 1999; 86(2):112-7. PubMed ID: 10545700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform.
    Lilleberg SL; Durocher J; Sanders C; Walters K; Culver K
    Ann N Y Acad Sci; 2004 Jun; 1022():250-6. PubMed ID: 15251969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
    Minamoto T; Mai M; Ronai Z
    Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutations of the APC, KRAS, and TP53 genes in nonpolypoid colorectal adenomas.
    van Wyk R; Slezak P; Hayes VM; Buys CH; Kotze MJ; de Jong G; Rubio C; Dolk A; Jaramillo E; Koizumi K; Grobbelaar JJ
    Genes Chromosomes Cancer; 2000 Feb; 27(2):202-8. PubMed ID: 10612810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of APC and k-ras mutations in the serum of patients with colorectal cancer.
    Lauschke H; Caspari R; Friedl W; Schwarz B; Mathiak M; Propping P; Hirner A
    Cancer Detect Prev; 2001; 25(1):55-61. PubMed ID: 11270422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multidisciplinary management of gastrointestinal cancer. The use of molecular markers in the diagnosis and treatment of colorectal cancer.
    Tejpar S
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1071-87. PubMed ID: 18070704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations in molecular detection of lymph node micrometastasis from colorectal cancer.
    Klebig F; Fischer C; Petri S; Gerull H; Wagener C; Tschentscher P
    Diagn Mol Pathol; 2007 Jun; 16(2):91-5. PubMed ID: 17525678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic pathways in colorectal cancer: interest for the pathologist].
    Piard F; Martin L; Chapusot C; Ponnelle T; Faivre J
    Ann Pathol; 2002 Sep; 22(4):277-88. PubMed ID: 12410150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent notions on intestinal cancerogenesis, their implications in genetic risk screening and preventive action of non-steroid anti-inflammatory agents].
    Couturier D
    Bull Acad Natl Med; 2002; 186(2):421-43; discussion 443-5. PubMed ID: 12145848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.
    Malesci A; Laghi L; Bianchi P; Delconte G; Randolph A; Torri V; Carnaghi C; Doci R; Rosati R; Montorsi M; Roncalli M; Gennari L; Santoro A
    Clin Cancer Res; 2007 Jul; 13(13):3831-9. PubMed ID: 17606714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular-pathological problems of genetic diagnosis for colorectal cancer].
    Tomita N; Monden T; Sekimoto M; Monden M
    Nihon Geka Gakkai Zasshi; 1997 Mar; 98(3):366-72. PubMed ID: 9101543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative pathological examination of colorectal cancer.
    Micev M; Cosic-Micev M; Todorovic V
    Acta Chir Iugosl; 2000; 47(4 Suppl 1):67-76. PubMed ID: 11432246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of cycling gradient capillary electrophoresis to detection of APC, K-ras, and DCC point mutations in patients with sporadic colorectal tumors.
    Minarik M; Minarikova L; Hrabikova M; Minarikova P; Hrabal P; Zavoral M
    Electrophoresis; 2004 Apr; 25(7-8):1016-21. PubMed ID: 15095442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer.
    Gnanasampanthan G; Elsaleh H; McCaul K; Iacopetta B
    J Pathol; 2001 Dec; 195(5):543-8. PubMed ID: 11745689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent advance of prognostic factor in human colorectal cancer].
    Itoh F; Yamamoto H; Fukushima H; Matsuno K; Imai K
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2028-35. PubMed ID: 9838903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 mutation in colorectal cancer.
    Iacopetta B
    Hum Mutat; 2003 Mar; 21(3):271-6. PubMed ID: 12619112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.